Mostrando 4 resultados de: 4
Filtros aplicados
Publisher
Annual Review of Medicine(1)
Clinical Cancer Research(1)
Endocrinology(1)
European Journal of Endocrinology(1)
Objetivos de Desarrollo Sostenible
ODS 10: Reducción de las desigualdades(4)
ODS 3: Salud y bienestar(4)
Origen
scopus(4)
3β-hydroxysteroid dehydrogenase is a possible pharmacological target in the treatment of castration-resistant prostate cancer
ArticleAbstract: Prostate cancer usually responds to androgen deprivation therapy, although the response in metastatiPalabras claves:Autores:Evaul K., Li R., Papari-Zareei M., Richard J. Auchus, Sharifi N.Fuentes:scopusAbiraterone acetate treatment lowers 11-oxygenated androgens
ArticleAbstract: Context: The human adrenal is the dominant source of androgens in castration-resistant prostate cancPalabras claves:Autores:Alyamani M., O'Day P.J., Richard J. Auchus, Sharifi N., Wright C.Fuentes:scopusMolecular pathways: Inhibiting steroid biosynthesis in prostate cancer
ReviewAbstract: A significant proportion of castration-resistant prostate cancers (CRPC) remains driven by ligand acPalabras claves:Autores:Attard G., Ferraldeschi R., Richard J. Auchus, Sharifi N.Fuentes:scopusSex Hormones and Prostate Cancer
ReviewAbstract: The prostate is an androgen-dependent organ that develops only in male mammals. Prostate cancer is tPalabras claves:prostate cancer, androgen, steroidogenesis, abiraterone acetate, adrenalAutores:Richard J. Auchus, Sharifi N.Fuentes:scopus